|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C12N 15/113 | (2010.01) |
| C12N 15/11 | (2006.01) | ||
| C12N 9/22 | (2006.01) | ||
| C12N 15/63 | (2006.01) |
| (11) | Number of the document | 3250691 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16704978.2 |
| Date of filing the European patent application | 2016-01-27 | |
| (97) | Date of publication of the European application | 2017-12-06 |
| (45) | Date of publication and mention of the grant of the patent | 2023-06-21 |
| (46) | Date of publication of the claims translation | 2023-09-11 |
| (86) | Number | PCT/US2016/015145 |
| Date | 2016-01-27 |
| (87) | Number | WO 2016/123230 |
| Date | 2016-08-04 |
| (30) | Number | Date | Country code |
| 201562108931 P | 2015-01-28 | US | |
| 201562251548 P | 2015-11-05 | US |
| (72) |
MAY, Andrew P. , US
DONOHOUE, Paul D. , US
|
| (73) |
Caribou Biosciences, Inc. ,
2929 7th Street
Suite 105, Berkeley, CA 94710,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | CRISPR hibridiniai DNR/RNR polinukleotidai ir naudojimo būdai |
| CRISPR HYBRID DNA/RNA POLYNUCLEOTIDES AND METHODS OF USE |
| Payment date | Validity (years) | Amount | |
| 2025-12-31 | 11 | 289.00 EUR |
| 2027-01-27 |